Neutralizing Antibodies for the COVID-19 treatment
Post Views: 1,523 The severe acute respiratory syndrome, also known as SARS-CoV-2 or the Covid-19 has caused unusual global health and economic dilemmas. Numerous vaccine strategies and repurposed drugs are currently under evaluation for safety and efficiency. Meanwhile, diverse neutralizing monoclonal antibodies (nMAbs) targeting SARS-CoV-2 spike glycoprotein are in diverging stages of clinical trials and…
